Quoin Pharmaceuticals Ltd. (QNRX) shareholders
Close on Nov 17, 2026Market cap $6.75MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Stonepine GP, LLC Joint filing with Stonepine Capital Management, LLC (9.99%), Stonepine Capital, L.P. (9.99%) and 1 more | 7,594,166 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Integrated Core Strategies (US) LLC Joint filing with Millennium Management LLC (5.50%), Millennium Group Management LLC (5.50%) and 1 more | 3,850,385 | 5.50% | 13G (passive) | May 26, 2026 |
| Stonepine Capital Management, LLC Joint filing with Stonepine Capital, L.P. (9.90%), Stonepine GP, LLC (9.90%) and 1 more | 3,030,926 | 9.90% | 13G (passive) | Dec 10, 2025 |
| Millennium Group Management LLC Joint filing with Integrated Core Strategies (US) LLC (9.00%), Millennium Management LLC (9.00%) and 1 more | 1,901,585 | 9.00% | 13G (passive) | Oct 20, 2025 |
| Neil Shahrestani Joint filing with Ikarian Capital, LLC (12.60%) | 211,538 | 12.60% | 13G (passive) amendment | Jan 31, 2026 |
| Aberdeen Group plc Joint filing with abrdn Inc. (8.94%) | 75,000 | 8.94% | 13G (passive) | Dec 31, 2025 |
| Daniel Schneeberger Joint filing with ADAR1 Capital Management, LLC (6.90%), ADAR1 Capital Management GP, LLC (6.00%) | 58,230 | 6.90% | 13G (passive) | Dec 31, 2025 |
| Resolute Capital Asset Partners LLC Joint filing with Resolute Capital Asset Partners Fund I LP (8.50%) | 50,000 | 8.50% | 13G (passive) | Oct 10, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of QNRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 214,987 | 10.70% | $1.04M | +18,395 | 0.82% |
| Ikarian Capital, LLC | 211,538 | 10.53% | $1.02M | – | 0.11% |
| Stonepine Capital Management, LLC | 199,486 | 9.93% | $965.51K | +146,026 | 0.54% |
| Millennium Management LLC | 112,323 | 5.59% | $543.64K | +36,076 | 0.00% |
| SummitTX Capital, L.P. | 100,300 | 4.99% | $485.45K | – | 0.01% |
| Woodline Partners LP | 76,446 | 3.81% | $370.00K | −3,136 | 0.00% |
| abrdn plc | 75,000 | 3.73% | $363.00K | – | 0.00% |
| Soleus Capital Management, L.P. | 72,730 | 3.62% | $352.01K | – | 0.01% |
| AIGH Capital Management LLC | 70,000 | 3.49% | $338.80K | +19,000 | 0.02% |
| Boothbay Fund Management, LLC | 59,838 | 2.98% | $289.62K | – | 0.00% |
| Velan Capital Investment Management LP | 32,372 | 1.61% | $156.68K | −52,477 | 0.10% |
| Barclays PLC | 21,469 | 1.07% | $103.91K | +20,169 | 0.00% |
| Birchview Capital, LP | 20,000 | 1.00% | $96.80K | – | 0.05% |
| XTX Topco Ltd | 15,006 | 0.75% | $72.63K | New | 0.00% |
| Morgan Stanley | 8,000 | 0.40% | $38.72K | +4,000 | 0.00% |
| UBS Group AG | 6,772 | 0.34% | $32.78K | +4,260 | 0.00% |
| Rhumbline Advisers | 2,332 | 0.12% | $11.28K | +811 | 0.00% |
| GAMMA Investing LLC | 439 | 0.02% | $2.13K | −1,281 | 0.00% |
| SBI Securities Co., Ltd. | 355 | 0.02% | $1.72K | +353 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 19 | 1M | 64.7% | 1 / 9 | 3 / 3 | 0M | 0M |
| Q1 2026 | 21 | 1M | 59.0% | 6 / 7 | 4 / 3 | 0M | 0M |
| Q4 2025 | 18 | 1M | 42.0% | 14 / 4 | 0 / 0 | 1M | 0M |
| Q3 2025 | 4 | 0M | 0.1% | 0 / 1 | 2 / 2 | 0M | 0M |
| Q2 2025 | 6 | 0M | 0.1% | 1 / 2 | 3 / 5 | 0M | 0M |
| Q1 2025 | 10 | 0M | 0.6% | 4 / 3 | 0 / 8 | 0M | 0M |
| Q4 2024 | 14 | 0M | 2.2% | 10 / 3 | 1 / 2 | 0M | 0M |
| Q3 2024 | 7 | 0M | 0.2% | 2 / 4 | 0 / 5 | 0M | 0M |
| Q2 2024 | 10 | 0M | 0.3% | 5 / 3 | 1 / 3 | 0M | 0M |
| Q1 2024 | 8 | 0M | 0.3% | 7 / 1 | 0 / 2 | 0M | 0M |
| Q4 2023 | 3 | 0M | 0.0% | 2 / 1 | 0 / 2 | 0M | 0M |
| Q3 2023 | 3 | 0M | 0.0% | 3 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael Myers | Chief Executive Officer, Director | 37,713 | 1.88% | Sep 1, 2026 |
| Denise P. Carter | Chief Operating Officer, Director | 37,709 | 1.88% | Sep 1, 2026 |
| Sally Bridget Lawlor | Chief Financial Officer | 10,684 | 0.53% | Sep 1, 2026 |
| Gordon Dunn | Chief Financial Officer | 151,077 | 7.52% | Dec 27, 2024 |
| Dennis Langer | Director | 49,687 | 2.47% | Oct 26, 2026 |
| Anthony James Culverwell | Director | 40,364 | 2.01% | Sep 1, 2026 |
| Michael T. Sember | Director | – | – | Feb 6, 2026 |
| Joseph Patrick Cooper | Director | – | – | Feb 6, 2026 |
| Natalie Ee Mun Leong | Director | – | – | Feb 6, 2026 |
| Stonepine Capital Management, LLC | 10% owner | 3,271,100 | 162.87% | Mar 31, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Denise P. Carter Chief Operating Officer, Director | Aug 31, 2026 | Buy | +20,490 | $4.88 | $99.99K | 37,709 |
| Sally Bridget Lawlor Chief Financial Officer | Aug 31, 2026 | Buy | +10,244 | $4.88 | $49.99K | 10,684 |
| Michael Myers Chief Executive Officer, Director | Aug 31, 2026 | Buy | +20,490 | $4.88 | $99.99K | 37,713 |
| Anthony James Culverwell Director | Aug 31, 2026 | Buy | +6,146 | $4.88 | $29.99K | 40,364 |
| Anthony James Culverwell Director | Aug 27, 2026 | Award | +31,352 | $5.15 | $161.46K | 34,218 |
| Dennis Langer Director | Aug 27, 2026 | Award | +34,534 | $5.15 | $177.85K | 56,243 |
| Dennis Langer Director | Oct 14, 2025 | Buy | +15,152 | $8.49 | $128.64K | 15,153 |
| Anthony James Culverwell Director | Dec 23, 2024 | Buy | +100,000 | $0.45 | $45.00K | 100,317 |
| Gordon Dunn Chief Financial Officer | Dec 23, 2024 | Buy | +122,221 | $0.45 | $55.00K | 151,077 |
| Denise P. Carter Chief Operating Officer, Director | Dec 23, 2024 | Buy | +555,556 | $0.45 | $250.00K | 602,648 |
| Michael Myers Chief Executive Officer, Director | Dec 23, 2024 | Buy | +555,556 | $0.45 | $250.00K | 602,808 |
| Gordon Dunn Chief Financial Officer | Sep 10, 2024 | Buy | +10,000 | $0.71 | $7.10K | 28,856 |
| Gordon Dunn Chief Financial Officer | Sep 10, 2024 | Buy | +10,000 | $0.91 | $9.10K | 18,856 |
| Gordon Dunn Chief Financial Officer | Sep 9, 2024 | Buy | +856 | $0.80 | $685 | 856 |
| Gordon Dunn Chief Financial Officer | Sep 9, 2024 | Buy | +4,000 | $0.78 | $3.12K | 4,856 |
| Gordon Dunn Chief Financial Officer | Sep 9, 2024 | Buy | +4,000 | $0.80 | $3.20K | 8,856 |
| Michael Myers Chief Executive Officer, Director | Sep 4, 2024 | Buy | +8,200 | $0.75 | $6.15K | 23,680 |
| Michael Myers Chief Executive Officer, Director | Sep 4, 2024 | Buy | +23,572 | $0.80 | $18.86K | 47,252 |
| Michael Myers Chief Executive Officer, Director | Sep 4, 2024 | Buy | +5,322 | $0.66 | $3.51K | 15,480 |
| Denise P. Carter Chief Operating Officer, Director | Sep 4, 2024 | Buy | +22,988 | $0.80 | $18.39K | 47,092 |
| Denise P. Carter Chief Operating Officer, Director | Sep 4, 2024 | Buy | +8,825 | $0.75 | $6.62K | 24,104 |
| Michael Myers Chief Executive Officer, Director | Sep 3, 2024 | Buy | +800 | $0.62 | $496 | 10,158 |
| Denise P. Carter Chief Operating Officer, Director | Sep 3, 2024 | Buy | +1,822 | $0.63 | $1.15K | 11,179 |
| Denise P. Carter Chief Operating Officer, Director | Sep 3, 2024 | Buy | +4,100 | $0.66 | $2.71K | 15,279 |
| Dennis Langer Director | Jun 7, 2024 | Sale | −297 | $0.73 | $217 | 53 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Quoin Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 182,046 shares on Aug 31, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dennis Langer Director | Jun 7, 2024 | 297 | $218 | Jun 7, 2024 | Pre IPO Offering |
See a number that looks wrong?